Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dopamine and Melatonin

supplement:

Melatonin

Research Papers that Mention the Interaction

The antagonism of melatonin in models of Parkinson's disease (PD) can reduce the severity of motor impairment associated with dopamine (DA) degeneration.
Chronobiology international  •  2007  |  View Paper
Plasma norepinephrine and dopamine levels in the supine position 60 minutes after melatonin administration were lower compared with placebo (P <.05 and P <.01, respectively).
American heart journal  •  2001  |  View Paper
There is some evidence in animals that dopamine DA ) affects melatonin secretion.
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  1987  |  View Paper
In accordance with changes in the expression levels of enzymes, dopamine production and cAMP synthesis determined in the culture medium and cell lysate were also suppressed by melatonin.
The Journal of Steroid Biochemistry and Molecular Biology  •  2017  |  View Paper
Melatonin inhibits the release of dopamine from amacrine cells and increases the light sensitivity of horizontal cells.
International review of cell and molecular biology  •  2013  |  View Paper
Dopamine and adrenergic receptor complexes form under a circadian-regulated cycle and directly modulate melatonin synthesis and release from the pineal gland.
PLoS biology  •  2012  |  View Paper
Dopamine and adrenergic receptor complexes form under a circadian-regulated cycle and directly modulate melatonin synthesis and release from the pineal gland.
PLoS biology  •  2012  |  View Paper
In Parkinson patients melatonin may, on the one hand, exacerbate symptoms (because of its putative interference with dopamine release ) and, on the other, protect against neurodegeneration (by virtue of its antioxidant properties and its effects on mitochondrial activity).
Inhibition of dopamine release by melatonin has been demonstrated in specific areas of the mammalian central nervous system (hypothalamus, hippocampus, medulla-pons, and retina).
Cellular and Molecular Neurobiology  •  2004  |  View Paper
Melatonin … [3H]dopamine release by 50% (IC50) at 20 pM with a maximal inhibitory effect (80%) at 1 nM. The partial agonists, i.e., N-acetyltryptamine (… inhibition 40%) showed various degrees of efficacy while none of the competitive melatonin receptor antagonists did inhibit [3H]dopamine release on their own.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  1997  |  View Paper
Surprisingly, only the stimulatory effect of dopamine could be inhibited by exposure to melatonin.
Endocrinology  •  1997  |  View Paper
Show More